James Demicco

Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention

Letter or commentary · Substance Abuse · 2019 · 10 citations

'Extreme duplication' in the US FDA Adverse Events Reporting System database

Letter or commentary · Drug Safety · 2007